Related Experiment Video
Updated: Aug 2, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Is Chronic Kidney Disease, a Predictor of In-Hospital Mortality in Coronavirus Disease 2019 (COVID-19) Patients?
Firouzeh Moeinzadeh1, Vahideh Raeisi2, Media Babahajiani3
1Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Chronic kidney disease (CKD) significantly increased COVID-19 mortality risk in initial analysis. However, after adjusting for other factors, this association was no longer significant, suggesting CKD may not be an independent predictor of mortality in COVID-19 patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Chronic kidney disease (CKD) is a prevalent comorbidity among patients with Coronavirus Disease 2019 (COVID-19).
- Understanding the impact of CKD on COVID-19 outcomes is crucial for patient management.
Purpose of the Study:
- To investigate the association between chronic kidney disease (CKD) and in-hospital mortality in patients diagnosed with Coronavirus Disease 2019 (COVID-19).
Main Methods:
- A cohort study involving 116 CKD patients and 147 control subjects with confirmed COVID-19.
- Data collected included demographics, clinical signs, symptoms, laboratory findings, and chest CT scans.
- Logistic regression models were employed to analyze the association between CKD and in-hospital mortality, with adjustments for confounders.
Main Results:
- The mortality rate was substantially higher in COVID-19 patients with CKD compared to those without (30.17% vs 4.76%, P < 0.001).
- Crude logistic regression indicated a significant correlation between CKD and in-hospital mortality (OR = 8.64).
- However, after full adjustment for confounders, the association between CKD and in-hospital mortality was not statistically significant in the total sample or gender subgroups (OR = 1.70).
Conclusions:
- While initial analyses suggested a link, this study indicates that chronic kidney disease (CKD) may not be an independent predictor of in-hospital mortality in COVID-19 patients after accounting for other risk factors.
- Intensive monitoring of COVID-19 patients with CKD is still recommended due to their higher observed mortality rates.
Background:
Chronic kidney disease (CKD) is an important comorbidity in Coronavirus Disease 2019 (COVID-19) patients considering its high prevalence. We aimed to figure out the relationship between CKD and COVID-19 mortality in this study.
Materials And Methods:
In total, 116 CKD patients (estimated glomerular filtration rate [eGFR] lower than 60 mL/min/1.73 m2) and 147 control subjects confirmed with COVID-19 were studied. Data regarding demographics, sign and symptoms, laboratory findings, and chest computed tomography were collected. Association between CKD and in-hospital mortality were analyzed using logistic regression models adjusted for confounders.
Results:
Mortality rate was significantly higher in CKD than non-CKD (30.17 vs 4.76, P < 0.001) COVID-19 patients. Multivariate logistic regression showed that CKD was significantly correlated with in-hospital mortality in the total sample (Odds ratio (OR) = 8.64, confidence interval (CI): 3.67-20.35) and gender subgroups (females: OR = 4.77, CI: 1.38-16.40, males: OR = 13.43, CI: 3.85-46.87) (P < 0.05) of COVID-19 patients in the crude model. Whereas, the correlation did not remain significant in the fully adjusted model in the total sample (OR = 1.70, CI: 0.35-8.19) and gender subgroups (females: OR = 1.07 CI: 0.06-19.82, males: OR = 0.87, CI: 0.07-10.33) (P > 0.05) of COVID-19 patients.
Conclusion:
This study suggested an independent association between CKD and in-hospital mortality in COVID-19 patients. Therefore, more intensive surveillance of COVID-19 patients with CKD is to be warranted.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology

